Oppenheimer analyst Leland Gershell lowered the price target on VBI Vaccines (NASDAQ: VBIV) to $5.00 (from $9.00) while maintaining an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE